Drug Profile
R 7232
Alternative Names: R7232Latest Information Update: 23 Jul 2009
Price :
$50
*
At a glance
- Originator Roche
- Class Antihyperlipidaemics; Small molecules
- Mechanism of Action Cholesterol ester transfer protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 16 Apr 2009 Discontinued - Phase-I for Hyperlipidaemia in Switzerland (unspecified route)